Equities

LeMaitre Vascular Inc

LeMaitre Vascular Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)80.09
  • Today's Change1.04 / 1.32%
  • Shares traded100.49k
  • 1 Year change+18.42%
  • Beta0.8844
Data delayed at least 15 minutes, as of Jun 14 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.

  • Revenue in USD (TTM)199.89m
  • Net income in USD33.95m
  • Incorporated1998
  • Employees614.00
  • Location
    LeMaitre Vascular Inc63 2nd AveBURLINGTON 01803-4413United StatesUSA
  • Phone+1 (781) 221-2266
  • Fax+1 (781) 425-5049
  • Websitehttps://www.lemaitre.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Coretag Inc0.00-34.52k1.13bn0.00---------0.3806-0.38060.00-0.98010.00-------3,303.35--------------------------10.95------
Establishment Labs Holdings Inc155.79m-82.76m1.22bn781.00--21.47--7.86-3.15-3.155.912.070.60950.91913.39171,579.30-32.38-33.22-39.25-41.1265.0164.73-53.12-43.192.73-21.300.7715--2.1321.96-4.38--69.16--
Owens & Minor, Inc.10.42bn-38.77m1.28bn13.70k--1.435.070.1226-0.5099-0.5099136.9811.711.986.7914.60760,861.20-0.73721.32-1.112.0720.7516.48-0.37190.56140.56482.190.70650.7983.801.87-284.47--25.91--
Alphatec Holdings Inc511.63m-191.60m1.49bn839.00--40.43--2.91-1.49-1.493.970.42940.76121.346.70609,808.10-28.51-30.97-37.13-39.4765.8966.02-37.45-46.221.49-5.170.8938--37.4539.38-23.36--67.92--
Adapthealth Corp3.25bn-695.41m1.51bn10.70k--1.03--0.4646-5.18-5.1824.2710.970.663721.668.30303,555.90-14.15-4.34-15.82-4.8918.4518.28-21.32-6.471.112.080.6025--7.73---1,169.99------
Inmode Ltd466.26m181.11m1.54bn581.008.661.858.493.312.112.115.429.870.59731.7116.09802,509.4023.2031.3225.2135.6483.1084.4638.8439.6512.66--0.000.008.3237.4922.5454.6513.10--
LeMaitre Vascular Inc199.89m33.95m1.80bn614.0053.065.8341.338.991.511.518.8913.740.59771.177.19325,548.9010.159.0210.999.9366.4565.8316.9915.455.31--0.0040.4119.6912.8845.895.9618.9315.51
Premier Inc1.34bn80.33m1.93bn2.80k28.631.009.791.440.64210.642111.3418.350.38875.253.10477,306.101.8910.392.4813.0066.2062.044.8722.600.8226143.620.27619.11-6.762.44-34.17-15.30-2.29--
Warby Parker Inc697.80m-55.06m1.93bn2.14k--6.09--2.76-0.467-0.4675.912.661.215.19655.52326,074.80-9.57---11.95--55.0157.49-7.89-14.532.02--0.00--11.9819.6742.75------
UFP Technologies Inc407.33m47.88m1.93bn3.09k40.566.5532.454.746.216.2152.8238.461.024.506.71131,693.2011.999.6913.8010.9527.8926.3311.7510.141.4617.870.10390.0013.0816.007.5025.7114.08--
STAAR Surgical Co326.24m15.30m2.03bn1.06k133.265.1597.856.210.30930.30936.628.000.71592.115.09308,942.303.366.773.827.9078.5176.894.699.165.22--0.00040.0013.3721.07-46.1833.8551.95--
Patterson Companies, Inc.6.57bn193.86m2.03bn7.60k11.162.107.240.30882.032.0368.8610.782.235.6114.48864,047.906.580.370211.300.565521.3021.052.950.18110.724312.080.4462846.10-0.42983.442.1410.798.220.00
Conmed Corp1.26bn82.35m2.19bn4.00k27.122.5614.191.742.622.6240.1227.760.5451.735.55315,387.003.560.89724.101.0254.9254.956.531.651.083.650.5369139.1619.067.68179.9910.042.890.00
Helen of Troy Limited2.01bn168.59m2.34bn1.93k13.961.4310.651.177.057.0583.6568.940.69712.485.191,040,503.005.867.696.909.5347.3144.328.419.240.99365.270.289---3.265.0917.67-0.65486.79--
Enovis Corp1.82bn-103.33m2.46bn6.55k--0.743318.131.35-1.89-1.5033.2960.330.37171.495.49277,452.20-2.10-0.3569-2.32-0.4158.1248.19-5.66-1.061.030.92430.2879--9.22-4.89-40.29--11.91--
Data as of Jun 14 2024. Currency figures normalised to LeMaitre Vascular Inc's reporting currency: US Dollar USD

Institutional shareholders

53.81%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Mar 20243.03m13.51%
Conestoga Capital Advisors LLCas of 31 Mar 20241.93m8.61%
The Vanguard Group, Inc.as of 31 Mar 20241.50m6.68%
Copeland Capital Management LLCas of 31 Mar 20241.29m5.75%
Geneva Capital Management LLCas of 31 Mar 2024900.04k4.01%
Ranger Investment Management LPas of 31 Mar 2024823.71k3.67%
SSgA Funds Management, Inc.as of 31 Mar 2024793.14k3.53%
Congress Asset Management Co. LLPas of 31 Mar 2024666.08k2.97%
Dimensional Fund Advisors LPas of 31 Mar 2024662.28k2.95%
Geode Capital Management LLCas of 31 Mar 2024477.64k2.13%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.